Cladribine as treatment of multiple sclerosis, real world experience

被引:0
|
作者
Celius, E. G.
Berg-Hansen, P.
机构
[1] Univ Oslo, Oslo Univ Hosp Ulleval, Neurol, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P998
引用
收藏
页码:527 / 528
页数:2
相关论文
共 50 条
  • [31] Two years efficacy and safety results from real world experience for cladribine tablets in management of relapsing multiple sclerosis in Qatar
    Garcia-Canibano, B.
    Zahir, F. Zamrath
    Safan, A.
    Ibrahim, F.
    Deleu, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 391 - 391
  • [32] Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States
    Song, Yan
    Wang, Yan
    Wong, Schiffon L.
    Yang, Danni
    Sundar, Manasvi
    Tundia, Namita
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [33] Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world study
    Brownlee, Wallace J.
    Haghikia, Aiden
    Hayward, Brooke
    Waser, Nathalie
    Kayaniyil, Sheena
    Khan, Zaeem
    Duncan, Julie
    Millar, Stefanie
    Harty, Gerard T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76
  • [34] Development of oral cladribine for the treatment of multiple sclerosis
    Hartung, Hans-Peter
    Aktas, Orhan
    Kieseier, Bernd
    Comi, Giancarlo
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 163 - 170
  • [35] The treatment of chronic progressive multiple sclerosis with cladribine
    Beutler, E
    Sipe, JC
    Romine, JS
    Koziol, JA
    McMillan, R
    Zyroff, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1716 - 1720
  • [36] Development of oral cladribine for the treatment of multiple sclerosis
    Hans-Peter Hartung
    Orhan Aktas
    Bernd Kieseier
    Giancarlo Comi
    Journal of Neurology, 2010, 257 : 163 - 170
  • [37] Cladribine Tablets' Potential in Multiple Sclerosis Treatment
    Costello, Kathleen
    Sipe, Jack C.
    JOURNAL OF NEUROSCIENCE NURSING, 2008, 40 (05) : 275 - 280
  • [38] Cladribine tablets in people with relapsing multiple sclerosis: a real-world multicentric, multinational study
    Adamec, I.
    Jakob, G. Brec
    Rajda, C.
    Drulovic, J.
    Radulovic, L.
    Kes, V. Basic
    Lazibat, I.
    Rimac, J.
    Cindric, I.
    Grzincic, T.
    Abicic, A.
    Barun, B.
    Gabelic, T.
    Gomezelj, S.
    Pekmezovic, T.
    Klivenyi, P.
    Skoric, M. Krbot
    Habek, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 180 - 180
  • [39] Real-world experience with cladribine in the MSBase Registry
    Butzkueven, H.
    Spelman, T.
    Hodgkinson, S.
    Madueno, S. Eichau
    Izquierdo, G.
    Buzzard, K.
    Skabina, O.
    Van der Walt, A.
    Kalincik, T.
    Grand-Maison, F.
    McCombe, P.
    Butler, E.
    Prevost, J.
    Van Pesch, V.
    Ozakbas, S.
    Macdonell, R.
    Oh, J.
    Alroughani, R.
    Lechner-Scott, J.
    Grammond, P.
    Sanchez-Menoyo, J. -L.
    Terzi, M.
    Duquette, P.
    Prat, A.
    Girard, M.
    Laureys, G.
    Van Hijfte, L.
    di Cantogno, E. Verdun
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 681 - 683
  • [40] Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy
    Lizak, Nathaniel
    Hodgkinson, Suzanne
    Butler, Ernest
    Lechner-Scott, Jeannette
    Slee, Mark
    McCombe, Pamela Ann
    Shaw, Cameron
    Skibina, Olga
    Vucic, Steve
    Shuey, Neil
    Barnett, Michael H.
    Parratt, John
    Butzkueven, Helmut
    Jack, Dominic
    Fabris, Jessica
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (03) : 465 - 474